| 2010
Leamon, Martin H.; Flower, Keith; Salo, Ruth E.; Nordahl, Thomas E.; Kranzler, Henry R.; Galloway, Gantt P.
The Methamphetamine Experience Questionnaire provides useful information on drug use variables that contribute to paranoia commonly associated with methamphetamine use. The link between methamphetamine use and symptoms of paranoia is well-known, but separating it from paranoia attributable to other causes has been challenging. Since there are some similarities between cocain and methamphetamine use, the MEQ was adapted from the Cocaine Experience Questionnaire (CEQ) to assess lifetime methamphetamine-induced paranoia.
The MEQ is a structured interview comprising 50 items with a number of branch and skip points. The instrument first ascertains whether subjects ever experienced paranoia while using methamphetamine, and if so, inquires further about those experiences. The instrument assesses lifetime prevalence of paranoia. It inquires about lifetime symptoms, defines paranoia as a persecutory delusion, and emphasizes the difference between paranoia that occurs specifically during meth use and other types of paranoid experiences. |
A copy of the MEQ is located in the Appendix of the Source Ref (Leamon, 2010). For more information, contact:
Dr. Martin H. Leamon
Department of Psychiatry and Behavioral Sciences
University of California, Davis
2230 Stockton Blvd.
Sacramento, CA 95817 U.S.A.
mhleamon@ucdavis.edu |
Permanent URL for this page:
http://bit.ly/MEQ_inst |
